Singular signs top US radiologist to pick up imaging rollout paceBill McConnellSponsoredThu, 3 July 2025 2:54PM
Western Australian medical technology innovator Singular Health Group has strengthened its push into the lucrative United States healthcare market with the appointment of a seasoned radiologist with more than two decades’ experience as its US radiology advisor.
In a move aimed squarely at cementing clinical credibility and accelerating commercialisation, Dr Alex Alonso will also set up Singular’s flagship 3DICOM radiology platform at his own diagnostic centre, Life Radiology FL, in Doral, Florida. The appointment follows Singular’s binding enterprise agreement with Provider Network Solutions (PNS), a leading US-based managed service organisation which manages more than 3.7 million patient plans across Florida, Texas and Puerto Rico.
Having Dr Alonso onboard as an approved radiology architect under our PNS partnership and seeing him deploy 3DICOM in his own centre is a massive endorsement. It validates our belief that our platform solves real-world problems faced by radiologists every day.
Singular Health managing director and chief executive officer Denning Chong
Chong described the appointment as a “big win”, noting his first-hand understanding of US imaging workflows and duplication challenges.
Alonso said the technology could solve everyday challenges for radiologists and patients.
“I see a real pathway to nationwide rollout in the US as we move towards connected, patient-focused care,” he said.
Life Radiology will integrate 3DICOM features such as interoperability between digital patient filing systems, secure image sharing and patient access portals to streamline diagnostic workflows and reduce unnecessary repeat imaging, which remains a significant cost burden on the US healthcare system.
Alonso’s consulting fees will be settled through the issue of fully paid ordinary Singular shares worth US$27,000 at the end of his six-month engagement, directly aligning his interests with the company’s shareholders.
Today’s appointment builds on a string of strategic milestones for Singular. Two weeks ago, the company inked a US$1.3 million (A$2 million) contract with PNS to roll out an initial 1000 3DICOM MD licences to doctors across Puerto Rico, Florida and Texas.
The contract includes a US$500,000 commitment to develop AI imaging models and a centralised image repository, key steps towards the company’s plan to address the endemic problem of duplicate imaging in the US. Industry studies estimate unnecessary imaging costs US healthcare up to US$30 billion annually.
The scale of Singular’s opportunity is underscored by independent research commissioned from Signify Research, estimating a total addressable market of US$19 billion annually for 3DICOM licences among 1.3 million US primary care doctors.
To support its ambitious US rollout, Singular Health raised $8 million through a placement of 22.4 million shares at 35 cents each, completed just last week. The raise attracted strong institutional support and saw strategic backers, including PNS, reinforce their confidence in Singular’s vision by participating in the placement. The fresh cash leaves the company fully funded for the planned national deployment of 3DICOM and further product development.
Quarterly reports further reveal the company’s solid operational and financial footing, with more than $5.3 million cash at bank as of the end of March. Recent achievements include the completion of the 3DICOM Gateway, a real-time browser-based tool enabling seamless sharing and access to imaging records, and the appointment of Australian radiologist Dr Ronny Low as technical advisor for the US pilot.
Looking ahead, Singular Health is preparing for its first large-scale national rollout across PNS’s partner networks, supported by its strategic joint venture between PNS and the Healthcare Outcomes Performance Company (HOPCo), a group operating across more than 30 US states.
Singular Health’s 3DICOM software, which has US Food and Drug Administration registration for diagnostic use in the US, enables advanced 3D visualisation of medical images, empowering practitioners and patients with clearer insights into imaging data. The company’s broader suite of technologies, including its volumetric rendering platform and medical file transfer protocol, aims to eliminate medical imaging silos and reduce costs, patient discomfort and delays in care.
As Singular Health sets its sights firmly on transforming the US medical imaging landscape, today’s appointment of Alonso represents a clinical endorsement and a significant leap forward in its mission to make healthcare imaging smarter, faster and more accessible across America.
Is your ASX-listed company doing something interesting? Contact: [email protected]
Get the latest news from thewest.com.au in your inbox.
Sign up for our emails
Read more on The West Australian
